NIFTy Trial
@niftytrial
The NIFTy Trial: NIRF Imaging to prevent PoSH after Thyroid Surgery - A phase II/III pragmatic, multicentre randomised controlled trial
ISRCTN: 59074092
ID: 1562730422542696451
25-08-2022 09:17:39
27 Tweet
32 Followers
16 Following
We would like to extend a warm welcome to Chelsea and Westminster Hospital to the NIFTy Trial who opened today! -Good luck with recruitment! #thyroidsurgery #surgicalresearch #hypopara #hypoparathyroidsim
📢Our 2 newest sites on the NIFTy Trial have recruited their first patients! Well done aimee di marco MA PhD FRCS & team at Hammersmith & the team at Chelsea and Westminster Hospital. What a fantastic start! 👏👏👏
👏Well done to the team at Hammersmith for recruiting participant no. 7⃣0⃣ to the NIFTy Trial. Also a big shout out to STHResearch&Innovation for randomising 7 participants in January! 👏Imperial NHS 💙 aimee di marco MA PhD FRCS Sabapathy Balasubramanian #thyroidsurgery #hypoparathyroidism #surgicalresearch
🔊Shout out to our highest recruiting NIFTy Trial site Lister & Stevenage who have recruited 4⃣ patients already this month taking them over 3⃣0⃣ randomisations so far. Well done & thank you for your support of the trial! George Mochloulis Carina Cruz #surgicalresearch #hypopara
📢February is shaping up to be another great month for the NIFTy Trial as we open our 5⃣th site to recruitment. Welcome to the team at UCLH - We are looking forward to working with you on this exciting trial! #hypoparathyroidism #thyroidsurgery #surgerytrials #surgicalresearch
📢February is shaping up to be another great month for the NIFTy Trial as we open our 5⃣th site to recruitment. Welcome to the team at UCLH - We are looking forward to working with you on this exciting trial! #hypoparathyroidism #thyroidsurgery #surgerytrials #surgicalresearch
February was another great month for NIFTy Trial Well done to our sites who recruited this month. We were also pleased to open UCLH to the trial too - welcome aboard! STHResearch&Innovation Sabapathy Balasubramanian aimee di marco MA PhD FRCS George Mochloulis Carina Cruz NIHR UCLH Biomedical Research Centre #hypopara #thyroidsurgery
March was our highest recruiting month to date on the NIFTy Trial with 1⃣7⃣ randomisations - well done to the sites who recruited in March 👏 We are so close to 100 participants - can we reach this milestone in April & who will recruit number 100? #hypopara #surgicalresearch
📢1⃣0⃣0⃣ Randomisations!!! Well done to our fantastic NIFTy Trial sites for your support of the trial. Recruitment is looking GREAT! Also, shout out to the team at Lister for Randomising participant no. 100! George Mochloulis Carina Cruz #thyroidsurgery #hypopara #surgicalresearch
The NIFTy Trial is now open to recruitment at Portsmouth! 🥳 Welcome Portsmouth Hospitals University NHST & good luck with recruitment. We now have 6⃣ sites open! 👏 Matt Ward 🇵🇸 #thyroidsurgery #surgicalresearch #hypopara #hypoparathyroidism #parathyroid
Congratulations to the teams at UCLH and Portsmouth for recruiting your 1st NIFTy Trial participants - great work! 👏👏 NIHR UCLH Biomedical Research Centre Portsmouth Hospitals University NHST Matt Ward 🇵🇸 #thyroidsurgery #surgicalresearch #hypoparathyroidism #endocrinesurgery
Join the British Association of Endocrine&Thyroid Surgeons webinar tomorrow evening to hear about the @NIFTyTrial
📢May was a great month for recruitment! All our NIFTy Trial sites randomised participants & we hit our highest monthly recruitment figure with 2⃣2⃣ randomisations! Well done & thank you to our fantastic teams for continuing to support the trial! 👏🙏#hypopara #thyroidsurgery
📢We have surpassed 1⃣5⃣0⃣ participants on the NIFTy Trial 👍 Well done to our fantastic sites especially Lister for recruiting no. 150 👏 Thank you to the sites for their continued support & of course, a great big thank you to the patients who agree to take part! #thyroidsurgery